Similar articles for PMID: 16499996

Year	Number of Results
1976	1
1981	1
1983	1
1984	2
1985	1
1986	3
1987	4
1988	3
1989	3
1990	6
1991	4
1992	1
1993	3
1994	2
1995	8
1996	2
1997	7
1998	6
1999	4
2000	3
2001	10
2002	15
2003	12
2004	22
2005	26
2006	16
2007	14
2008	17
2009	14
2010	13
2011	14
2012	11
2013	17
2014	7
2015	10
2016	15
2017	10
2018	9
2019	11
2020	10
2021	4
2024	0

1

Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.

Stinchcombe TE, Morris DE, Moore DT, Bechtel JH, Halle JS, Mears A, Deschesne K, Rosenman JG, Socinski MA. Stinchcombe TE, et al. Lung Cancer. 2006 Apr;52(1):67-74. doi: 10.1016/j.lungcan.2005.11.008. Epub 2006 Feb 24. Lung Cancer. 2006. PMID: 16499996

2

High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.

Zhao L, West BT, Hayman JA, Lyons S, Cease K, Kong FM. Zhao L, et al. Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):103-10. doi: 10.1016/j.ijrobp.2006.11.051. Epub 2007 Mar 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17363189

3

A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.

Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS. Cho KH, et al. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1397-404. doi: 10.1016/j.ijrobp.2008.10.020. Epub 2008 Dec 29. Int J Radiat Oncol Biol Phys. 2009. PMID: 19117690 Clinical Trial.

4

Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.

Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M. Srisam-Ang K, et al. Southeast Asian J Trop Med Public Health. 2005 Jul;36(4):994-1006. Southeast Asian J Trop Med Public Health. 2005. PMID: 16295558

5

[Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].

Yu DP, Bai LQ, Xu SF, Han M, Wang ZT. Yu DP, et al. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):465-8. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950561 Chinese.

6

Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.

Werner-Wasik M, Swann RS, Bradley J, Graham M, Emami B, Purdy J, Sause W. Werner-Wasik M, et al. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):385-90. doi: 10.1016/j.ijrobp.2007.06.034. Epub 2007 Sep 14. Int J Radiat Oncol Biol Phys. 2008. PMID: 17869017 Clinical Trial.

7

Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?

Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Langer CJ, et al. Lung Cancer. 2005 Apr;48(1):93-102. doi: 10.1016/j.lungcan.2004.09.005. Lung Cancer. 2005. PMID: 15777975

8

Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.

Basaki K, Abe Y, Aoki M, Kondo H, Hatayama Y, Nakaji S. Basaki K, et al. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):449-54. doi: 10.1016/j.ijrobp.2005.07.967. Epub 2005 Oct 13. Int J Radiat Oncol Biol Phys. 2006. PMID: 16226400

9

Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.

Moreno-Jiménez M, Aristu J, López-Picazo JM, Ramos LI, Gúrpide A, Gómez-Iturriaga A, Valero J, Martínez-Monge R. Moreno-Jiménez M, et al. Radiother Oncol. 2008 Sep;88(3):342-50. doi: 10.1016/j.radonc.2008.05.019. Epub 2008 Jun 14. Radiother Oncol. 2008. PMID: 18558448

10

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.

Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR Jr, Moran C, Allen PK, Komaki R. Huang EH, et al. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):779-85. doi: 10.1016/j.ijrobp.2007.01.002. Epub 2007 Apr 6. Int J Radiat Oncol Biol Phys. 2007. PMID: 17418967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

312 results

Results by year